Janssen’s Multiple Myeloma Drug Among 11 Products To Get EMA Thumbs Up

Labeling Extension In Store For Bavarian Nordic’s Smallpox Vaccine To Include Monkeypox

The European Medicines Agency has cleared the decks for the pan-EU approval of nearly a dozen new drugs. Tecvayli is headed for a conditional approval, while Nulibry is slated to get marketing authorization under exceptional circumstances. 

Multiple myeloma cells emitting M (Monoclonal) protein in the blood flow - isometric view 3d illustration
Janssen’s Tecvayli Is A Novel Bispecific Antibody To Treat Multiple Myeloma • Source: Alamy

More from Approvals

More from Product Reviews